United Drug hires Abbott VP
June 19, 2013Manufacturing and Production, Research and Development, Sales and Marketing Abbott, United Drug
Healthcare services firm United Drug has appointed Brendan McAtamney as chief operating officer with effect from September. McAtamney will be …
GSK receives thrombosis offer
June 19, 2013Sales and Marketing GSK, aspen, thrombosis
GlaxoSmithKline has received an offer from South African firm Aspen Global Incorporated (AGI) to buy its injectable thrombosis treatments and …
Lilly pays Transition $7 million
June 19, 2013Research and Development, Sales and Marketing Transition, lilly
Eli Lilly is to take up its option to develop and commercialise a type 2 diabetes candidate, paying Canadian firm …
AstraZeneca chooses Cambridge for global HQ
June 19, 2013Research and Development, Sales and Marketing AstraZeneca, Cambridge, MedImmune
AstraZeneca has chosen the Cambridge Biomedical Campus on the outskirts of the city as a new research and corporate hub. …
Is Google Glass hospital ready?
June 19, 2013Medical Communications Google glass, langevin, venturebeat
Google Glass has the potential to greatly enhance medical practices in a number of ways. Among these is the ability to retrieve, …
DJM Digital Solutions appoints senior vice president
June 19, 2013Medical Communications, Sales and Marketing Creston, DJM
Digital healthcare agency DJM Digital Solutions has appointed Ray Manna as senior vice president, North America. Manna will report to …
Avastin gets GBM approval
June 18, 2013Research and Development, Sales and Marketing GBM, Roche, avastin
Roche has received a major boost with the first approval in early treatment of the most aggressive form of brain …
MedImmune signs diabetes deal
June 18, 2013Research and Development, Sales and Marketing AstraZeneca, MedImmune, diabetes
AstraZeneca R&D subsidiary MedImmune has signed a deal with privately-owned San Francisco-based NGM Biopharmaceuticals to discover novel therapeutics to treat …
J&J to pay up to $1 billion in Aragon deal
June 18, 2013Research and Development, Sales and Marketing Aragon, J&J, JJ, Zytiga
Johnson & Johnson could pay as much as $1 billion to buy prostate cancer specialist Aragon Pharmaceuticals. The acquisition includes …
Quality issues ‘leading cause of drug shortages’
June 18, 2013Manufacturing and Production ISPE, shortages
Shortages of key medicines have been increasing in recent years, and a new survey from the International Society for Pharmaceutical …
Cmed Group Showcases Trial Delivery Capabilities at DIA 2013
June 17, 2013Research and Development
Cmed Group will showcase its full-service CRO capabilities at the DIA’s Annual Meeting 2013 (June 23-27, 2013, Boston Convention and …
New ABPI director of communications announced
June 17, 2013Medical Communications, Research and Development, Sales and Marketing ABPI, Meadden, Whitehead
The ABPI has appointed its head of Policy and Public Affairs Catherine Meaden to be the organisation’s new director of …
Eisai’s £8 million UK expansion
June 17, 2013Manufacturing and Production Eisai
Eisai has decided to invest further into its Hertfordshire production plant in the UK towards the creation of an additional …
ICON appoints executive vice president
June 17, 2013Manufacturing and Production, Research and Development, Sales and Marketing ICON
Clinical research organisation ICON has appointed Dr Neil McCullough as executive vice president of Quality and Compliance and Corporate Training.McCullough …
John LaMattina: Pharma’s R&D deals with foundations may hit reputations
June 17, 2013Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing John LaMattina
On the surface, it sounds pretty reasonable. Foundations like the Michael J. Fox Foundation and the Cystic Fibrosis Foundation (CFF), …
UK gene scientist honoured with knighthood
June 17, 2013Medical Communications, Research and Development, Sales and Marketing Cancer, genes, knighthood, mike stratton, personalised
A British scientist who helped discover the BRCA breast cancer gene and paved the way for personalised medicine has been …
Catalent breaks ground on $35m controlled-release facility
June 17, 2013Manufacturing and Production Catalent
Catalent Pharma Solutions has started construction of a new facility at its site in Winchester, Kentucky, that will boost its …
No evidence of fault at Teva plant linked to drug switch death
June 14, 2013Manufacturing and Production Teva, death
France’s medicines regulator has concluded that a plant operated in the country by generic drugmaker Teva was not at fault …
Leo exaggerates Picato properties
June 14, 2013Medical Communications, Sales and Marketing ABPI, LEO Pharma, PMCPA
Leo Pharma has been censured by the PMCPA for not maintaining high standards over an advertisement that overreached itself when …
PAREXEL appoints senior VP and CFO
June 14, 2013Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Parexel
Biopharma services provider PAREXEL has appointed Ingo Bank to be a senior VP and chief financial officer at the firm. …
Latest content
Five Facts about NHS and primary care
AI in pharma: From lab development to patient impact
